fbpx
X
Popular Searches
Hemato-Oncology Cancer Treatment Rehabilitation Children Cancer Treatment CAR T THERAPY

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
x New Patient Current or Returning Refer a patient
search
stethoscope
default doctor image

Rinat Bernstein Molho

  • MD
Department:
  • Breast Cancer Unit
  • Oncology Institute
Specialties:
  • Medical Oncology
  • Medical Geneticist
Languages:
  • English
  • Hebrew
  • Russian
Request Consultation

About

Dr. Rinat Bernstein-Molho graduated from Israeli Institute of Technology Medical School in Haifa at 2004. She completed her residency in Medical Oncology and then an additional residency in Medical Genetics at Tel Aviv Medical Center. She was in charge of oncogenetic clinic at Tel Aviv Medical Center.

She joined Breast Cancer institute in the Sheba Medical Center at Tel Hashomer in 2017, where she works as a medical oncologist and clinical cancer geneticist. Her area of clinical and research interest is hereditary cancers.

Conditions and treatment

Positions

  • Senior specialist at Breast Cancer Unit, Oncology Institute

Education and Training

  • Dr. Rinat Bernstein Molho graduated with honors from the Faculty of Medicine at Technion University, Haifa.
  • She then specialized in Oncology at the Department of Oncology, Tel Aviv Medical Center.
  • Also she specialized in Genetics at the Institute of Genetics, Tel Aviv Medical Center.

Board Certifications

  • Oncology

Publications

Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel. Kenan ES, Friger M, Shochat-Bigon D, Schayek H, Bernstein-Molho R, Friedman E.

The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations. Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, Kalis ML, Peretz T, Shohat M, Basel-Salmon L, Friedman E, Bazak L, Goldberg Y.

Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort. Sella T, Gal Yam EN, Levanon K, Rotenberg TS, Gadot M, Kuchuk I, Molho RB, Itai A, Modiano TM, Gold R, Kaufman B, Shimon SP.

All publications

Sheba Knowledge Base

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly:

New Patient Current & Returning Patients Refer a Patient